Pharmaceuticals Company Reports & Industry Analysis
If you’re searching for objective information on top pharmaceutical companies—including emerging and established players—look no further. MarketResearch.com offers a vast collection of reports that provide detailed insights into a company’s organizational structure and key offerings within the pharmaceutical industry. These reports are valuable resources for identifying potential clients and partners, as well as gaining a deeper understanding of the strengths and weaknesses of competitors.
Pharmaceutical Company Profiles
- Access financial analysis, strategic assessments, SWOT analyses, and information on collaboration and licensing deals.
- Gain expert insights on prominent competitors such as Pfizer, Roche, Merck, AstraZeneca, Sanofi, Eli Lilly, and more.
- Browse reports from various research firms such as GlobalData, MarketLine, Current Partnering, Plunkett Research, and many others.
A Reliable Source for Research
Our pharmaceutical company reports provide you with crucial data and insights from leading market research firms around the world. Whether you are conducting due diligence, or looking to expand into new markets, our research delivers the strategic intelligence needed for success. For decades, organizations across the value chain have chosen us as their trusted partner. Browse our reports today for unmatched value and convenience.
Pharmaceuticals Company Reports Industry Research & Market Reports
-
Grupo Ferrer Internacional S.A. - Strategy, SWOT and Corporate Finance Report
... the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Grupo Ferrer Internacional S.A. (Ferrer or 'the company') is a provider of pharmaceuticals ... Read More
-
PDL BioPharma Inc (PDLI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for PDL BioPharma Inc (PDLI:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Dicerna Pharmaceuticals Inc (DRNA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Dicerna Pharmaceuticals Inc (DRNA:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Infosys and Top Pharma Bring Digital Transformation to Drug Manufacturing Data
... in biopharmaceutical manufacturing hold great potential for speeding lifesaving and life-improving drugs to manufacture while improving quality and efficiency. As pressure increases on drug companies to lower prices and costs, digital transformation in manufacturing data ... Read More
-
Antares Pharma Inc (ATRS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Antares Pharma Inc (ATRS:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Catalyst Pharmaceutical Partners, Inc. (CPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Catalyst Pharmaceutical Partners, Inc. (CPRX:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. ... Read More
-
Cocrystal Pharma Inc (COCP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Cocrystal Pharma Inc (COCP:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Conatus Pharmaceuticals Inc (CNAT:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Conatus Pharmaceuticals Inc (CNAT:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
BioDelivery Sciences International Inc (BDSI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Within its Industry Key Findings: Unique new report provides deep financial benchmarks for BioDelivery Sciences International Inc (BDSI:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. ... Read More
-
Aerpio Pharmaceuticals Inc (ARPO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Aerpio Pharmaceuticals Inc (ARPO:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Arena Pharmaceuticals Inc (ARNA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Arena Pharmaceuticals Inc (ARNA:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Armata Pharmaceuticals Inc (ARMP:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Armata Pharmaceuticals Inc (ARMP:ASE) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Aridis Pharmaceuticals Inc (ARDS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Aridis Pharmaceuticals Inc (ARDS:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
AMAG Pharmaceuticals Inc (AMAG:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for AMAG Pharmaceuticals Inc (AMAG:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Alexion Pharmaceuticals Inc (ALXN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Alexion Pharmaceuticals Inc (ALXN:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Agios Pharmaceuticals Inc (AGIO:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Agios Pharmaceuticals Inc (AGIO:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Adamas Pharmaceuticals Inc (ADMS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Adamas Pharmaceuticals Inc (ADMS:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Acceleron Pharma Inc (XLRN:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Acceleron Pharma Inc (XLRN:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Eyegate Pharmaceuticals Inc (EYEG:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
... Industry Key Findings: Unique new report provides deep financial benchmarks for Eyegate Pharmaceuticals Inc (EYEG:NAS) compared to its top competitors and compared to the average for all companies within its primary industry. Benchmarking study for ... Read More
-
Health & Happiness (H&H) International Holdings Ltd in Consumer Health (World)
... in 15 countries. The company has established a leading position in global consumer health. The acquisition of Australian-founded brand Swisse in 2016 has helped the group to expand its business to adult nutrition, and the ... Read More
-
19th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production
... organizations’ current and projected future capacity and production. This report’s ~500 pages of data-rich analysis will help improve your decision-making in biomanufacturing operations, with in-depth analysis of capacity, production trends, benchmarks, and much more. In-depth ... Read More
-
Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
AstraZeneca Plc - Enterprise Tech Ecosystem Series
... (CVRM), respiratory, and others. AstraZeneca markets its products under various brand names including Byetta, Casodex, Faslodex, Zoladex, Tagrisso, Iressa, Symbicort, Pulmicort, Lynparza, Nexium, Onglyza, etc. The company sells its products to specialty care and primary ... Read More
-
H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ... Read More
-
GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review
... a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your ... Read More
Research Assistance
